Bacteriotherapy: the time has come

Open Access
Publisher Website
Google Scholar
Abstract
References 1.↵ Root RK, Sande MA Sanders WE, Sanders C .Modification of normal flora by antibiotics: effects on individuals and the environment. In: Root RK, Sande MA eds.New dimensions in antimicrobial therapy: contemporary issues in infectious diseases.New York: Churchill Livingstone,1984:217–241. 2.↵ Roos K, Grahn Håkansson E, Holm S .Effect of recolonisation with “interfering” α streptococci on recurrences of acute and secretory otitis media in children; randomised placebo controlled trial.BMJ2001;322:210–212. 3.↵ Roos K, Holm SE, Grahn-Håkansson E, Lagergren L .Recolonization with selected alfa-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis—a randomised placebo-controlled multicentre study.Scand J Infect Dis1996;28:459–462. 4.↵ Nurmi E, Rantala M .New aspects of Salmonella infection in broiler production.Nature1973;241:210–211. 5.↵ Smith HS, Hughes JP, Hooton TM, Roberts P, Scholes D, Stergachis A, et al .Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women.Clin Infect Dis1997;25:63–68. 6.↵ Tvede M, Rask-Madsen J .Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.Lancet1989;i:1156–1160. 7.↵ McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al .A randomised placebo-controlled trial of Saccharimyces boulardii in combination with standard antibiotics for Clostridium difficile disease.JAMA1994;271:1913–1918. 8.↵ Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, et al .Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial.BMJ2001;322:1327–1329. 9.↵ Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, et al .Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomised study.Pediatrics1999;104: e64. 10.↵ Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon A .Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.Lancet1999;354:635–639. 11.↵ Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al .The effects of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland.N Engl J Med1997;337:441–446. 12.↵ Huovinen P, Cars O .Control of antimicrobial resistance: time for action.BMJ1998;317: 613. 13.↵ Hooper L, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI .Molecular analysis of commensal host-microbial relationship in the intestine.Science2001;291:881–884.